Literature DB >> 14769574

An alternative analysis of intraoperative parathyroid hormone data may improve the ability to detect multiglandular disease.

Paul G Gauger1, Michelle H Mullan, Norman W Thompson, Gerard M Doherty, Keith A Matz, Barry G England.   

Abstract

HYPOTHESIS: A nomogram based on regression analysis of intraoperative parathyroid hormone level decay discriminates single gland disease from multiglandular (MG) disease more accurately than the currently used 50% rule.
DESIGN: Retrospective case series.
SETTING: Academic health center. PATIENTS: Two hundred thirty-five patients (222 patients with single gland disease and 13 patients with MG disease) who underwent parathyroidectomy.
INTERVENTIONS: Intraoperative parathyroid hormone level analysis at baseline, time 1 (about 5 minutes), and time 2 (about 10 minutes) after excision of the first gland. MAIN OUTCOME MEASURES: The mean slope was calculated at time 1 and time 2 and analyzed using one-way analysis of variance and the Fisher least significance difference post hoc tests using data normalized to baseline intraoperative parathyroid hormone levels to compare patients with single gland disease with patients with MG disease. A regression-based nomogram was created to analyze individual kinetic decay data.
RESULTS: The mean (SEM) single gland disease slope was significantly steeper than the MG disease slope at both time 1 (-0.91 [0.02] vs -0.66 [0.05]; P<.01) and time 2 (-0.77 [0.01] vs -0.56 [0.05]; P<.01). When the standard threshold rule of a 50% decrease from baseline was used, only 23% of the patients with MG disease were correctly predicted by intraoperative parathyroid hormone values (77% false-positive result rate) at time 1. However, the nomogram correctly predicted 54% of the patients with MG disease at time 1 (46% false-positive result rate). At time 2, the standard threshold 50%-rule method correctly predicted 38% of the patients with MG disease (62% false-positive result rate), while the nomogram still correctly classified 54% of the patients with MG disease (46% false-positive result rate).
CONCLUSIONS: A regression-based nomogram incrementally improves prediction of MG disease compared with the standard 50%-rule method and accounts for variability in the exact timing of samples. Slope analysis suggests that the earliest time point best isolates the kinetics of the excised gland. The nomogram will need to be validated prospectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769574     DOI: 10.1001/archsurg.139.2.164

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

1.  Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy.

Authors:  Marcin Barczynski; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Stanislaw Cichon; Wojciech Nowak
Journal:  Langenbecks Arch Surg       Date:  2009-06-16       Impact factor: 3.445

2.  PTH spikes during parathyroid exploration--a possible pitfall during PTH monitoring?

Authors:  Philipp Riss; Klaus Kaczirek; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2006-12-23       Impact factor: 3.445

3.  Intraoperative parathyroid hormone monitoring in patients with recognized multiglandular primary hyperparathyroidism.

Authors:  David T Hughes; Barbra S Miller; Gerard M Doherty; Paul G Gauger
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 4.  Intraoperative adjuncts in surgery for primary hyperparathyroidism.

Authors:  Barney J Harrison; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

5.  When initial postexcision PTH level does not fall appropriately during parathyroidectomy: what to do next?

Authors:  Patrick B O'Neal; Vitaliy Poylin; Peter Mowschenson; Sareh Parangi; Gary Horowitz; Pravin Pant; Per-Olof Hasselgren
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

6.  Utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing in guiding patients with a negative sestamibi scan for minimally invasive parathyroidectomy--a randomized controlled trial.

Authors:  Marcin Barczynski; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Stanislaw Cichon; Wojciech Nowak
Journal:  Langenbecks Arch Surg       Date:  2009-06-16       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.